How we work

Putting patients before profits

How we work

Putting patients before profits

DNDi acts as a conductor of a ‘virtual orchestra’ of over 180 partners around the world to develop treatments for patients – not profits. By bringing together the public, private, academic, non-profit, and philanthropic sectors, we leverage the unique expertise of each partner to drive innovation for neglected populations.

A dynamic portfolio

In order to be able to respond to the constant evolution of public health needs, we have adopted a “dynamic portfolio” approach, which allows us to take on new disease areas with various operating models, while delivering on our objectives in diseases that we have worked on since our early days as a public interest R&D organization.  

This approach, enshrined in the Business Plan 2015-23, is instrumental in that it allows us to pursue a variety of different intervention models. Thanks to the dynamic portfolio, DNDi has added mycetoma to its R&D portfolio, co-created and then incubated GARDP as an entity to accelerate R&D for drug-resistant infections, and more recently, embarked on a new project on cryptococcal meningitis.